Skip to main content

Table 2 Clinical features of miR-93-3p/105 and miR-301b/181a-3p TNBC patients

From: miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer

 

miR-301b/181a-3p

miR-93-3p/105

Both low

One

Both high

P

Both low

One

Both high

P

Local metastasis

   

0.086

   

0.676

 No

209

314

183

 

173

355

178

 

 Yes

143

284

166

 

157

295

141

Distal metastasis

   

0.487

   

0.006*

 No

260

425

259

 

256

476

212

 

 Yes

92

173

90

 

74

174

107

Grade

   

0.002*

   

0.063

 1

25

59

22

 

32

57

17

 

 2

163

221

118

 

127

264

111

 3

144

289

194

 

153

296

178

Null

20

29

15

 

18

33

13

Stage

   

0.186

   

0.344

 0

3

4

6

 

4

3

6

 

 1

107

176

104

 

101

197

89

 2

151

299

168

 

163

293

162

 3

25

45

30

 

20

58

22

 4

4

4

2

 

2

6

2

Null

62

70

39

 

40

93

38